scispace - formally typeset
F

Falk Hildebrand

Researcher at Norwich University

Publications -  87
Citations -  16383

Falk Hildebrand is an academic researcher from Norwich University. The author has contributed to research in topics: Microbiome & Metagenomics. The author has an hindex of 32, co-authored 74 publications receiving 11776 citations. Previous affiliations of Falk Hildebrand include Norwich Research Park & University of Sussex.

Papers
More filters
Journal ArticleDOI

Structure and function of the soil microbiome underlying N2O emissions from global wetlands

TL;DR: In this article , the authors examined the potential role of archaea, bacteria, and fungi in nitrogen cycling and N2O emissions in wetland soils and provided evidence that despite their much lower abundance compared to bacteria, nitrifying archaeal abundance is a key factor explaining N 2O emissions from wetland soil globally.
Journal ArticleDOI

Addition of acacia gum to a FOS/inulin blend improves its fermentation profile in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®)

TL;DR: The Simulator of the Human Intestinal Microbial Ecosystem (SHIME®) was used to assess the impact of the partial substitution of FOS and inulin by acacia gum in a fibre blend and exerted a diverse modulating activity in the different areas of the colon.
Journal ArticleDOI

Draft Genome Sequence Analysis of a Pseudomonas putida W15Oct28 Strain with Antagonistic Activity to Gram-Positive and Pseudomonas sp. Pathogens

TL;DR: P. putida W15Oct28, isolated from a stream in Brussels, was found to produce compound(s) with antimicrobial activity against the opportunistic pathogens Staphylococcus aureus, Pseudomonas aeruginosa, and the plant pathogen PseUDomonas syringae.
Journal ArticleDOI

The chemical interactome space between the human host and the genetically defined gut metabotypes.

TL;DR: It is concluded that the abundance of the Prevotella genera is a key factor indicating a low metabolic potential, and connections between the systemic effects of non-antibiotic drugs and the gut microbiome of relevance to drug side effects and health-care solutions are established.